Yoga from home: new study tests if digital classes ease prostate cancer side effects
NCT ID NCT07158138
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will test whether an internet-based yoga program can help men with prostate cancer manage stress, urinary problems, and quality of life. 220 men who have been treated for prostate cancer will be randomly assigned to either the digital yoga program or standard care. The researchers will measure stress, incontinence, blood pressure, and quality of life over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- digital yoga intervention
- What this could lead to
- If it works, this could offer a convenient, low-cost way to improve quality of life and reduce stress for prostate cancer survivors.
- What could go wrong
- This is a relatively small trial testing a behavioral intervention, so results may not be generalizable. The effect on stress and incontinence may be modest or not clinically significant.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 220 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: are men diagnosed with prostate cancer without signs of metastatic disease, treated with curative intent. They should be Swedish-speaking and literate. Participants can be included within two months of diagnosis \- Exclusion Criteria: * are individuals under active surveillance or with advanced disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prostate cancer patients are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Health Care Center
Örebro, Region Örebro County, 70185, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single radiation type spare prostate cancer patients from extra side effects?
- Can a Triple-Drug cocktail before surgery curb prostate Cancer's return?
- AI chatbot aims to demystify prostate cancer radiation — a trial puts it to the test
- Exercise may counteract side effects of prostate cancer hormone therapy
- Combination therapy aims to wipe out High-Risk prostate cancer before surgery
- Can a digital guide boost genetic testing in prostate cancer survivors?